Targeting energy metabolism to eliminate cancer cells

References

• StewartBWWildCPWorld Cancer Report 2014Lyon, FranceWHO201412
   Google Scholar
• WHO [webpage on the Internet]Fact Sheets by Cancer2012 [cited June 2017[Available from: http://globocan.iarc.frAccessed June 7, 2018
   Google Scholar
• TorreLABrayFSiegelRLFerlayJLortettieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• WheelerHEMaitlandMLDolanMECoxNJRatainMJCancer pharmacogenomics: strategies and challengesNat Rev Genet2013141233423183705
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAThe hallmarks of cancerCell20001001577010647931
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• WarburgOOn the origin of cancer cells on the origin of cancerSource Sci New Ser1956123123309314
   PubMedGoogle Scholar
• ZuXLGuppyMCancer metabolism: facts, fantasy, and fictionBiochem Biophys Res Commun2004313345946514697210
   PubMed Web of Science ®Google Scholar
• NunnariJSuomalainenAMitochondria: in sickness and in healthCell201214861145115922424226
   PubMed Web of Science ®Google Scholar
• NicoteraPLeistMFerrando-MayEIntracellular ATP, a switch in the decision between apoptosis and necrosisToxicol Lett19981021038139142
   Google Scholar
• EguchiYShimizuSTsujimotoYIntracellular ATP levels determine cell death fate by apoptosis or necrosisCancer Res19975710183518409157970
   PubMed Web of Science ®Google Scholar
• IzyumovDSAvetisyanAVPletjushkinaOY“Wages of fear”: transient threefold decrease in intracellular ATP level imposes apoptosisBiochim Biophys Acta Bioenerg200416581–2141147
   Web of Science ®Google Scholar
• VasevaAVMarchenkoNDJiKTsirkaSEHolzmannSMollUMP53 opens the mitochondrial permeability transition pore to trigger necrosisCell201214971536154822726440
   PubMed Web of Science ®Google Scholar
• BrownNSBicknellRHypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancerBreast Cancer Res20013532332711597322
   PubMed Web of Science ®Google Scholar
• SullivanLBChandelNSMitochondrial reactive oxygen species and cancerCancer Metab2014211725671107
   PubMedGoogle Scholar
• ZhaoLRenTHWangDDClinical pharmacology considerations in biologics developmentActa Pharmacol Sin201233111339134723001474
   PubMed Web of Science ®Google Scholar
• ToMSAromatarisECCastroJRobertsMLBarrittGJRychkovGYMitochondrial uncoupler FCCP activates proton conductance but does not block store-operated Ca2+ current in liver cellsArch Biochem Biophys2010495215215820060804
   PubMed Web of Science ®Google Scholar
• KenwoodBMWeaverJLBajwaAIdentification of a novel mitochondrial uncoupler that does not depolarize the plasma membraneMol Metab20143211412324634817
   PubMed Web of Science ®Google Scholar
• EllinghausPHeislerIUnterschemmannKBAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex ICancer Med20132561162424403227
   PubMed Web of Science ®Google Scholar
• SchöckelLGlasauerABasitFTargeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growthCancer Metab2015311126500770
   PubMedGoogle Scholar
• KimKKAbelmanSYanoNTetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cellsSci Rep201551429626469226
   PubMed Web of Science ®Google Scholar
• OlivaCRMarkertTRossLJIdentification of small molecule inhibitors of human cytochrome c oxidase that target chemoresistant glioma cellsJ Biol Chem201629146241882419927679486
   PubMed Web of Science ®Google Scholar
• OlivaCRNozellSEDiersAAcquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chainJ Biol Chem201028551397593976720870728
   PubMed Web of Science ®Google Scholar
• CluntunAALukeyMJCerioneRALocasaleJWGlutamine metabolism in cancer: understanding the heterogeneityTrends Cancer20173316918028393116
   PubMed Web of Science ®Google Scholar
• Marín-HernándezAGallardo-PérezJCRodríguez-EnríquezSEncaladaRMoreno-SánchezRSaavedraEModeling cancer glycolysisBiochim Biophys Acta Bioenerg201118076755767
   PubMed Web of Science ®Google Scholar
• AltenbergBGreulichKOGenes of glycolysis are ubiquitously over-expressed in 24 cancer classesGenomics20048461014102015533718
   PubMed Web of Science ®Google Scholar
• BilliardJDennisonJBBriandJQuinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cellsCancer Metab2013111924280423
   PubMedGoogle Scholar
• BerndtNHamiltonADSebtiSMTargeting protein prenylation for cancer therapyNat Rev Cancer2011111177579122020205
   PubMed Web of Science ®Google Scholar
• CafforioPDammaccoFGernoneASilvestrisFStatins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cellsCarcinogenesis200526588389115705602
   PubMed Web of Science ®Google Scholar
• AbdullahMIAbedMNRichardsonAInhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cellsSci Rep201771809028808351
   PubMedGoogle Scholar
• WoschekMKneipNJuridaKMarziIReljaBSimvastatin reduces cancerogenic potential of renal cancer cells via geranylgeranyl pyrophosphate and mevalonate pathwayNutr Cancer201668342042727042994
   PubMed Web of Science ®Google Scholar
• PolańskiRHodgkinsonCLFusiAActivity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancerClin Cancer Res201420492693724277449
   PubMed Web of Science ®Google Scholar
• BolaBMChadwickALMichopoulosFInhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transportMol Cancer Ther201413122805281625281618
   PubMed Web of Science ®Google Scholar
• DohertyJRYangCScottKENBlocking lactate export by inhibiting the myc target MCT1 disables glycolysis and glutathione synthesisCancer Res201474390892024285728
   PubMed Web of Science ®Google Scholar
• Azevedo-SilvaJQueirósOBaltazarFThe anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedsideJ Bioenerg Biomembr201648434936227457582
   PubMed Web of Science ®Google Scholar
• PedersenPL3-Bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective “small molecule” anti-cancer agent taken from labside to bedside: introduction to a special issueJ Bioenerg Biomembr20124411622382780
   PubMed Web of Science ®Google Scholar
• ShoshanMC3-Bromopyruvate: targets and outcomesJ Bioenerg Biomembr201244171522298255
   PubMed Web of Science ®Google Scholar
• Jardim-MessederDMoreira-PachecoF3-Bromopyruvic acid inhibits tricarboxylic acid cycle and glutaminolysis in HepG2 cellsAnticancer Res20163652233224127127128
   PubMed Web of Science ®Google Scholar
• PaiardiniATramontiASchirchDDifferential 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer metabolic reprogrammingBiochim Biophys Acta20161864111506151727530298
   PubMed Web of Science ®Google Scholar
• El SayedSMBaghdadiHZolalyMAlmaramhyHHAyatMDonkiJGThe promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: an evidence-based viewMed Hypotheses2017100677728236852
   PubMed Web of Science ®Google Scholar
• KoYHVerhoevenHALeeMJCorbinDJVoglTJPedersenPLA translational study “case report” on the small molecule “energy blocker” 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedsideJ Bioenerg Biomembr201244116317022328020
   PubMed Web of Science ®Google Scholar
• IsraelsenWJVander HeidenMGPyruvate kinase: function, regulation and role in cancerSemin Cell Dev Biol201543435126277545
   PubMed Web of Science ®Google Scholar
• DongGMaoQXiaWPKM2 and cancer: the function of PKM2 beyond glycolysis (review)Oncol Lett20161131980198626998110
   PubMed Web of Science ®Google Scholar
• MazurekSPyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cellsInt J Biochem Cell Biol201143796998020156581
   PubMed Web of Science ®Google Scholar
• WalshMJBrimacombeKRAnastasiouDdatabase on the InternetML265: A Potent PKM2 Activator Induces Tetramerization and Reduces Tumor Formation and Size in a Mouse Xenograft Model2010 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23905203Accessed June 7, 2018
   Google Scholar
• BrimacombeKRAnastasiouDHongBSML285 affects reactive oxygen species’ inhibition of pyruvate kinase M2Probe Reports from the NIH Molecular Libraries Program50Bethesda, MDNational Center for Biotechnology Information (US)2010118
   Google Scholar
• AnastasiouDYuYIsraelsenWJPyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesisNat Chem Biol201281083984722922757
   PubMed Web of Science ®Google Scholar
• KungCHixonJChoeSSmall molecule activation of pkm2 in cancer cells induces serine auxotrophyChem Biol20121991187119822999886
   PubMed Web of Science ®Google Scholar
• ParnellKMFoulksJMNixRNPharmacologic activation of PKM2 slows lung tumor xenograft growthMol Cancer Ther20131281453146023720766
   PubMed Web of Science ®Google Scholar
• KimDJParkYSKimNDA novel pyruvate kinase M2 activator compound that suppresses lung cancer cell viability under hypoxiaMol Cells201538437337925813626
   PubMed Web of Science ®Google Scholar
• FuLZhangSZhangLSystems biology network-based discovery of a small molecule activator BL-AD008 targeting AMPK/ZIPK and inducing apoptosis in cervical cancerOncotarget20156108071808825797270
   PubMedGoogle Scholar
• ZadraGPhotopoulosCTyekuchevaSA novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesisEMBO Mol Med20146451953824497570
   PubMed Web of Science ®Google Scholar
• McDonaldPCChafeSCDedharSOvercoming hypoxia-mediated tumor progression: combinatorial approaches targeting pH regulation, angiogenesis and immune dysfunctionFront Cell Dev Biol201642727066484
   PubMed Web of Science ®Google Scholar
• TangCYuJHypoxia-inducible factor-1 as a therapeutic target in cancerJ Gastroenterol Hepatol201328340140523173651
   PubMed Web of Science ®Google Scholar
• CavadasMANguyenLKCheongAHypoxia-inducible factor (HIF) network: insights from mathematical modelsCell Commun Signal20131114223758895
   PubMed Web of Science ®Google Scholar
• PengGLiuYHypoxia-inducible factors in cancer stem cells and inflammationTrends Pharmacol Sci201536637438325857287
   PubMed Web of Science ®Google Scholar
• ShenCNettletonDJiangMKimSKPowell-CoffmanJARoles of the HIF-1 hypoxia-inducible factor during hypoxia response in Caenorhabditis elegansJ Biol Chem200528021205802058815781453
   PubMed Web of Science ®Google Scholar
• MajmundarAJWongWJSimonMCHypoxia-inducible factors and the response to hypoxic stressMol Cell201040229430920965423
   PubMed Web of Science ®Google Scholar
• DenglerVLGalbraithMDEspinosaJMTranscriptional regulation by hypoxia inducible factorsCrit Rev Biochem Mol Biol2015491115
   Web of Science ®Google Scholar
• ChoiSHChungARKangWSilencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxiaPLoS One201497e10330425068796
   PubMed Web of Science ®Google Scholar
• TsaiY-PWuK-JHypoxia-regulated target genes implicated in tumor metastasisJ Biomed Sci201219110223241400
   PubMedGoogle Scholar
• WardCLangdonSPMullenPNew strategies for targeting the hypoxic tumour microenvironment in breast cancerCancer Treat Rev201339217117923063837
   PubMed Web of Science ®Google Scholar
• HuFShiLMuRHypoxia-inducible factor-1α and interleukin 33 form a regulatory circuit to perpetuate the inflammation in rheumatoid arthritisPLoS One201388814
   Web of Science ®Google Scholar
• LiGLuWWuXAdmission hypoxia-inducible factor 1α levels and in-hospital mortality in patients with acute decompensated heart failureBMC Cardiovasc Disord2015157926223692
   PubMed Web of Science ®Google Scholar
• ShenHMakiCGPharmacologic activation of p53 by small-molecule MDM2 antagonistsCurr Pharm Des201117656056821391906
   PubMed Web of Science ®Google Scholar
• DevineTDaiM-STargeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapyCurr Pharm Des201319183248326223151129
   PubMed Web of Science ®Google Scholar
• WelshSWilliamsRKirkpatrickLPaine-MurrietaGPowisGAntitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alphaMol Cancer Ther20043323324415026543
   PubMed Web of Science ®Google Scholar
• KohMYSpivak-KroizmanTVenturiniSMolecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1Mol Cancer Ther2008719010018202012
   PubMed Web of Science ®Google Scholar
• GreenbergerLMHorakIDFilpulaDA RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growthMol Cancer Ther20087113598360818974394
   PubMed Web of Science ®Google Scholar
• BorsiEPerroneGTerragnaCHypoxia inducible factor-1 alpha as a therapeutic target in multiple myelomaOncotarget2014571779179224732040
   PubMedGoogle Scholar
• JeongWRapisardaAParkSRPilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumorsCancer Chemother Pharmacol201473234334824292632
   PubMed Web of Science ®Google Scholar
• BanHSKimBKLeeHThe novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growthCell Death Dis201786e284328569777
   PubMedGoogle Scholar
• TurnerNLiJYGosbyABerberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate amp-activated protein kinase and improve insulin actionDiabetes20085751414141818285556
   PubMed Web of Science ®Google Scholar
• ProtopopovaMMadhaviBJenniferBIACS-10759: a novel OXPHOS inhibitor which selectively kill tumors with metabolic vulnerabilitiesCancer Res2015754380
   Web of Science ®Google Scholar
• BastianAMatsuzakiSHumphriesKMAG311, a small molecule inhibitor of complex I and hypoxia-induced HIF-1α stabilizationCancer Lett201738814915727939695
   PubMed Web of Science ®Google Scholar
• MiyaderaHShiomiKUiHAtpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase)Proc Natl Acad Sci U S A2003100247347712515859
   PubMed Web of Science ®Google Scholar
• HuangLSSunGCobessiD3-Nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzymeJ Biol Chem200628195965597216371358
   PubMed Web of Science ®Google Scholar
• WangLZhangXCuiGA novel agent exerts antitumor activity in breast cancer cells by targeting mitochondrial complex IIOncotarget201672211126700963
   PubMedGoogle Scholar
• LimSHWuLKiewLVChungLYBurgessKLeeHBRosamines targeting the cancer oxidative phosphorylation pathwayPLoS One201493e8293424622277
   PubMed Web of Science ®Google Scholar
• XiaoDPowolnyAAMouraMBPhenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cellsJ Biol Chem201028534265582656920571029
   PubMed Web of Science ®Google Scholar
• GohilVMShethSANilssonRNutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysisNat Biotechnol201028324925520160716
   PubMed Web of Science ®Google Scholar
• CelaOPiccoliCScrimaRBupivacaine uncouples the mitochondrial oxidative phosphorylation, inhibits respiratory chain complexes I and III and enhances ROS production: results of a study on cell culturesMitochondrion201010548749620546950
   PubMed Web of Science ®Google Scholar
• MorrellJAOrmeJButlinRJRocheTEMayersRMKilgourEAZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2Biochem Soc Trans200331Pt 61168117014641019
   PubMedGoogle Scholar
• MooreJDStaniszewskaAShawTVER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cellsOncotarget2014524128621287625404640
   PubMedGoogle Scholar
• VarshneyRDwarakanathBSJainVRadiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cellsInt J Radiat Biol200581539740816076755
   PubMed Web of Science ®Google Scholar
• Ganapathy-KanniappanSKunjithapathamRGeschwindJFAnticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targetingAnticancer Res2013331132023267123
   PubMed Web of Science ®Google Scholar
• ClemBTelangSClemASmall-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growthMol Cancer Ther20087111012018202014
   PubMed Web of Science ®Google Scholar
• TelangSO’NealJTapolskyGIdentification of a PFKFB3 inhibitor suitable for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenibCancer Metab20142Suppl 11425215185
   PubMedGoogle Scholar
• LeACooperCRGouwAMInhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progressionProc Natl Acad Sci U S A201010752037204220133848
   PubMed Web of Science ®Google Scholar
• ChenJXieJJiangZWangBWangYHuXShikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2Oncogene201130424297430621516121
   PubMed Web of Science ®Google Scholar
• JungDWKimWHParkSHA unique small molecule inhibitor of enolase clarifies its role in fundamental biological processesACS Chem Biol2013861271128223547795
   PubMed Web of Science ®Google Scholar
• LiXTangSWangQ-QIdentification of epigallocatechin-3-gallate as an inhibitor of phosphoglycerate mutase 1Front Pharmacol201781928149278
   PubMed Web of Science ®Google Scholar
• SujobertPPoulainLPaubelleECo-activation of AMPK and mTORC1 induces cytotoxicity in acute myeloid leukemiaCell Rep20151191446145726004183
   PubMed Web of Science ®Google Scholar
• KungALZabludoffSDFranceDSSmall molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathwayCancer Cell200461334315261140
   PubMed Web of Science ®Google Scholar
• SapraPKraftPPastorinoFPotent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effectsAngiogenesis201114324525321452059
   PubMed Web of Science ®Google Scholar
• TerzuoliEPuppoMRapisardaAAminoflavone, a ligand of the aryl hydrocarbon receptor (AhR), inhibits HIF-1α expression in an AhR-independent fashionCancer Res2011701768376848
   Web of Science ®Google Scholar
• KuboTMaezawaNOsadaMKatsumuraSFunaeYImaokaSBisphenol A, an environmental endocrine-disrupting chemical, inhibits hypoxic response via degradation of hypoxia-inducible factor 1alpha (HIF-1alpha): structural requirement of bisphenol A for degradation of HIF-1alphaBiochem Biophys Res Commun200431841006101115147973
   PubMed Web of Science ®Google Scholar
• YeoE-JChunY-SChoY-SYC-1: a potential anticancer drug targeting hypoxia-inducible factor 1J Natl Cancer Inst200395751652512671019
   PubMedGoogle Scholar
• JonesDTHarrisALIdentification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA bindingMol Cancer Ther2006592193220216985052
   PubMed Web of Science ®Google Scholar
• NaritaTYinSGelinCFIdentification of a novel small molecule HIF-1α translation inhibitorClin Cancer Res200915196128613619789328
   PubMed Web of Science ®Google Scholar
• Moreno-ManzanoVRodríguez-JiménezFJAceña-BonillaJLFM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation statusJ Biol Chem201028521333134219897487
   PubMed Web of Science ®Google Scholar
• WelshSJWilliamsRRBirminghamANewmanDJKirkpatrickDLPowisGThe thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formationMol Cancer Ther20032323524312657718
   PubMed Web of Science ®Google Scholar
• LeeKKangJEParkSKLW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1α via upregulation of VHL in a colon cancer cell lineBiochem Pharmacol201080798298920599784
   PubMed Web of Science ®Google Scholar
• MinegishiHFukashiroSBanHSNakamuraHDiscovery of indenopyrazoles as a new class of hypoxia inducible factor (HIF)-1 inhibitorsACS Med Chem Lett20134229730124900662
   PubMed Web of Science ®Google Scholar
• LeeSHJeeJGBaeJSLiuKHLeeYMA group of novel HIF-1α inhibitors, glyceollins, blocks HIF-1α synthesis and decreases its stability via inhibition of the PI3K/AKT/mTOR pathway and Hsp90 bindingJ Cell Physiol2015230485386225204544
   PubMed Web of Science ®Google Scholar
• MabjeeshNJEscuinDLaValleeTM2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIFCancer Cell20033436337512726862
   PubMed Web of Science ®Google Scholar
• KongDParkEJStephenAGEchinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activityCancer Res200565199047905516204079
   PubMed Web of Science ®Google Scholar
• NguyenTDJinXLeeJHAbietane diterpenes from Salvia miltiorrhiza inhibit the activation of hypoxia-inducible factor-1J Nat Prod20077071093109717583950
   PubMed Web of Science ®Google Scholar
• WallaceEMRizziJPHanGA small-molecule antagonist of HIF2α is efficacious in preclinical models of renal cell carcinomaCancer Res201676185491550027635045
   PubMed Web of Science ®Google Scholar
• ChenWHillHChristieATargeting renal cell carcinoma with a HIF-2 antagonistNature2016539762711211727595394
   PubMed Web of Science ®Google Scholar